DFPH — Starling Oncology, Inc.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1799191 ·
Last close
$2.01
Market Cap
$436.37M
52W High
$2.01
52W Low
$1.80
ADV30
0
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 564,851 | 47,480 | -222,356 | -175,596 | 1,834,279 | 326,522 | 943,337 |
| Mar 2026 | 365,054 | 78,784 | -230,328 | -216,715 | 1,832,831 | 859,269 | 719,412 |
| Dec 2025 | 120,890 | 23,263 | -232,001 | -226,397 | 2,085,584 | 1,322,102 | 735,600 |
| Sep 2025 | 220,849 | 133,948 | -112,370 | -112,756 | 1,680,193 | 1,363,759 | 283,663 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-448,792
Investing CF
$-660,205
Financing CF
$70,263
CapEx
$-17,038
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-11-08
Balance + Analyst (yfinance extras)
Retained Earnings
$-2,853,641
Inventory
$91,137
Receivables
$152,690
ST Investments
—
EBIT TTM
$-797,055
Pretax Income TTM
$-789,397
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,271,644
EBITDA
$-627,345
Free Cash Flow
$-525,999
Enterprise Value
$436,084,192
Total Cash
$349,128
Total Debt
$99,508
Shares Out
217,111,050
Trailing EPS
$0.00
Book Value
$0.00
ROE
-65.5%
ROA
-27.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 3y)
Revenues vs Net Income (last 3y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Sep 2025 | 1,152,084 | -423,962 | -453,527 | 1,680,193 | 283,663 | 1,396,530 | -505,898 |
| Sep 2024 | 1,483,227 | -313,531 | -334,397 | 2,282,249 | 439,310 | 1,842,939 | -235,188 |
| Sep 2023 | 1,216,130 | -244,502 | -714,332 | 816,810 | 106,280 | 710,530 | -215,101 |
TTM Snapshot
Revenues TTM
$587,244,000
NetIncome TTM
$-36,293,000
OpCashFlow TTM
—
Assets (Latest)
$178,233,000
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MCTA | Charming Medical Ltd | $445.55M | $29.35 | — |
| STLN | Starling Oncology, Inc. | $346.51M | $3.40 | — |
| VMD | VIEMED HEALTHCARE, INC. | $343.69M | $9.07 | — |
| YDES | YD Bio Ltd | $335.03M | $4.73 | — |
| SBC | SBC Medical Group Holdings Inc | $629.42M | $6.12 | — |
Recent Insider Activity
No insider activity indexed for this ticker.